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Synopsis 
Input into multidisciplinary tumor boards (MTB) by all core disciplines is crucial for making 
treatment recommendations. Patients’ psychosocial information stimulates decision-making, and 
must be considered by MTBs, while comorbidities, or those requiring nursing input suggest 
complexity, and decision-making is impaired. 
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Abstract  
Background. In many healthcare systems, treatment recommendations for cancer patients are 
formulated by multidisciplinary tumor boards (MTBs). Evidence suggests that interdisciplinary 
contributions to case reviews in the meetings are unequal and information sharing suboptimal, with 
biomedical information dominating over information on patient comorbidities and psychosocial 
factors. This study aimed to evaluate how different elements of the decision process affect teams’ 
ability to reach a decision on first case review. 
Methods. This is an observational quantitative assessment of 1,045 case reviews from 2010-2014 in 
cancer MTBs using a validated tool, the Metric for the Observation of Decision-making. The tool 
allows evaluation of the quality of information presentation (case history, radiological, pathological, 
and psychosocial information, comorbidities, and patient views), and contribution to discussion by 
individual core specialties (surgeons, oncologists, radiologists, pathologists, and specialist cancer 
nurses). The teams’ ability to reach a decision was a dichotomous outcome variable (yes/no).  
Results. Using multiple logistic regression analysis, the significant positive predictors of teams’ 
ability to reach a decision were patient psychosocial information (OR=1.35), surgeons’ (OR=1.62), 
radiologists’ (OR=1.48), pathologists’ (OR=1.23), and oncologists’ inputs (OR=1.13). The 
significant negative predictors were patient comorbidity information (OR=0.83), and nursing inputs 
(OR=0.87). 
Conclusions. Multidisciplinary inputs into case reviews and patient psychosocial information 
stimulate decision-making, thereby reinforcing the role of MTBs in cancer care in processing such 
information. Information on patients’ comorbidities, and nursing inputs make decision-making 
harder, possibly indicating that a case is complex and requires more detailed review.   
Research should further define case complexity and determine ways to better integrate patient 
psychosocial information into decision-making. 
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Introduction  
Cancer diagnosis and treatment are complex processes and must be tailored to individual patients. 
To meet these demands, and ensure the delivery of safe and high quality care, cancer patients are 
reviewed by multidisciplinary tumor boards (MTB), or cancer conferences. Throughout the world, 
combinations of healthcare professionals, including surgeons, physicians, oncologists, radiologists, 
pathologists and specialist cancer nurses comprise MTBs. The specialists participating in MTBs 
formulate treatment plans to optimize care and improve patient outcomes [1]. As the number of new 
cancer cases worldwide rises [2, 3] against a backdrop of increasing financial pressure [3, 4], the 
effectiveness of MTBs is central for delivery of patient-centered, high value care.  
Despite a central role in many healthcare systems [1], evidence supporting the effectiveness of 
MTBs is unclear [5], and their performance can be variable [6]. The past decade has seen 
developments in research on MTBs, with studies examining the team decision-making process, 
decision implementation, and patient participation. A recurring pattern in decision-making is the 
skewed contribution to case reviews towards physicians and the biomedical aspect of the disease, at 
the expense of nursing input (even where specialist nurses are formally in attendance), patients’ 
comorbidities and psychosocial circumstances [7-9]. The general consensus, however, is that 
patient-centered, holistic clinical decisions underpin high-quality patient care [3, 8, 10-11]. There is 
evidence that failure to account for patients’ social circumstances [12] and comorbidities [9] has a 
negative impact on the ability of MTB’s to implement treatment recommendations [12]. Other 
studies have shown reduced costs [13] and improved care [14] when decisions are aligned with 
patients’ needs and preferences. The quality of MTB decision-making is a cornerstone of effective 
care planning.  
The aim of this study is to assess the relative influence of different elements of the decision-making 
process on the ability of MTBs to reach clinical decisions. We hypothesize that all aspects of patient 
information (H1), as well as inputs by all core specialties (H2) will increase MTB’s ability to make 
treatment recommendations.  
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Methods 
Participants and Setting  
This is a secondary analysis of an existing anonymised database containing quantitative 
observational data. The data represent quality assessments of 1,045 cancer patient case reviews 
across four teams specializing in the commonest tumors in the UK, namely, breast (n=224), 
colorectal (n=185), lung (n=254) and urological (n=382). The data were collected between 2010 
and 2014 from National Health Service hospitals: one teaching university hospital with 
approximately 1500 beds (lung) and three community hospitals with approximately 500‒1000 beds 
(breast, colorectal, urological). The participating institutions and MTBs operate independently of 
one another with no crossover of MTB membership. Inclusion criteria were broad with the 
eligibility for the study being defined as the healthcare staff who are members of a cancer MTB. All 
teams consisted of a chair and coordinator (team administrator), as well as the senior cancer 
specialists, i.e., surgeons, oncologists, radiologists, pathologists, and cancer nurses, with the 
exception of lung where a chest physician was also present. 
The data were collected in real-time over 10 consecutive meetings for each tumor type by the 
researchers, who were surgeons trained in observational assessment (breast=SA, colorectal=SMS, 
lung=SS, urological=BWL). The researchers were not members of the MTBs that they were 
assessing. The reliability between evaluators was assessed in a subset of cases scored in pairs as per 
standard evidence-based recommendation for such analyses [15]. During data collection, each 
evaluator was blind to the other evaluators’ observations to minimize bias. All data were collated 
for analysis by a separate researcher (TS). The participating MTBs had previously been recruited to 
participate in separate research projects [e.g. 16-18]. At the time of data collection ethical approvals 
were in place for all hospitals/teams, and informed consent was obtained verbally from all MTB 
members (REC reference for urology MTB is 10/H0805/32; at lung, colorectal and breast MTBs the 
study was reviewed and approved as clinical service evaluation). Patient consent was not required 
due to the statistical, non-interventional nature of the study.   
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Materials  
Cases within each MTB were rated using a validated, behaviorally anchored observational tool, the 
Metric for the Observation of Decision-Making in multidisciplinary tumor boards (MTB-MODe), 
Figure 1 [7]. The process of tool development and validation has been reported in detail [7, 16-17, 
19-21]. MTB-MODe allows an evaluator to rate the following elements on five-point behaviorally 
anchored scales:  
(i) Quality of information presentation at the meeting, including patient history, radiology 
results, pathology results, psychological and social factors, medical and surgical comorbidity, and 
patients’ wishes or opinions regarding treatment.  
(ii) Quality of contribution to decision making by MTB members (chairperson, surgeon, 
oncologist, specialist cancer nurse, radiologist, and histopathologist). Chairing was rated on the 
basis of the National Cancer Action Team guidelines [21]. Other members were rated on the basis 
of their specialty contribution based on the scale anchors.  
The outcome measure was whether or not a clear treatment decision was reached for a patient 
(yes/no).  
No patient identifiable or further clinical data were collected, as the focus of the study was on the 
clinical decision process within the MTB. The study dataset was distinct from the clinical data 
collected by the MTB administrator and used for care planning, and was not revealed to members of 
the MTB during the study to minimize any biases.  
 
------------------------------ 
Figure 1 
------------------------------ 
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Analyses 
Collected data were tabulated using Microsoft Excel. All analyses were undertaken using SPSS® 
version 20.0 software. 
Inter-assessor reliability 
A subset of cases was evaluated independently (also in real time) by a second researcher to assess 
inter-assessor reliability (see 15-17 for inter-assessor reliability within individual MTBs). The cases 
that were rated by the additional researcher were chosen at random. Researchers were blinded to 
each other’s ratings. Intraclass correlation coefficients (ICCs) were calculated; these range between 
0 and 1, with higher values indicating better agreement between evaluators. A reliability coefficient 
of 0.70 is considered as a minimum value for team-derived data to be used for research purposes 
[22].   
Regression analyses 
To identify factors that predict teams’ ability to reach treatment recommendation on first case 
review, we conducted a purposeful selection of variables using univariate logistic regression to 
identify items for the subsequent multiple logistic regression analysis [23]. Twelve individual 
variables of MTB-MODe representing the information and contribution quality were included in the 
regression modelling as predictors (all scored on 1-5 scales), and teams’ ability to reach a decision 
as a dichotomous outcome variable (scored yes/no). Univariate regression examined the relation of 
each of the twelve variables individually to the outcome, whereas multiple regression examined the 
relation of all twelve items to the outcome while controlling for each other. Statistical significance 
level was adjusted to 0.15 for univariate regression, and 0.10 for multiple regression in order to 
minimize the chances of failing to identify important variables, and discrepancy between the two 
regression methods – as per recommendations for such analyses [23]. Odds ratios in relation to a 
MTB reaching a decision on first case review are reported. Finally, to clarify any overlap between 
significant predictors as revealed by these models we also conducted partial correlation analyses 
controlling for tumor type.  
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Results 
Inter-assessor Reliability 
Inter-assessor reliability was analysed using ICCs on a subset of 273 cases. High reliability was 
obtained across all tumors: breast: median ICC=0.92 (range 0.27-1.00); colorectal: median 
ICC=0.83 (range 0.69-0.96); lung: median ICC=0.86 (range 0.71–0.99); and urological: median 
ICC=0.71 (range 0.31-0.87).  
Regression Analyses   
In the univariate analysis, all variables except chairs’ input reached significance (see Table 1) and 
were therefore entered into the multiple regression model (see Table 2). Table 2 shows that after 
adjusting for tumor type, positive significant predictors of treatment decisions were patient 
psychosocial information (Wald(1)=8.18), as well as the inputs to case reviews by radiologists 
(Wald(1)=17.27), pathologists (Wald(1)=4.11), surgeons (Wald(1)=39.48), and oncologists 
(Wald(1)=2.64). Negative significant predictors were patients’ comorbidities (Wald(1)=3.61), and 
nurses’ input (Wald(1)=2.74). The remaining variables were not significant. Figure 2 shows the 
odds ratio of each of these predictors on the probability of making a recommendation for a patient. 
The inputs of radiologists’ and surgeons’ predicted the greatest increase of the odds of reaching a 
decision. Nurses’ input and patient comorbidity information decreased these odds. To facilitate 
interpretation, the odds ratios were converted to probability percentages based on the following 
formula: odds/(odds+1)x100=probability% [24]. 
------------------------------ 
Tables 1 & 2 
------------------------------ 
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------------------------------ 
Figure 2 
------------------------------ 
Finally, the partial correlation analyses between significant predictors (as revealed in the 
multivariate models) and controlling for tumor type are reported in Table 3. These show that 
psychosocial information and comorbidities correlate mostly with the nurses’ input – thus 
corroborating the pattern obtained in the multiple regressions. We return to these findings in the 
Discussion.  
------------------------------ 
Table 3 
------------------------------ 
Discussion  
The findings of this study partially support our hypotheses. Our first hypothesis (H1) was that the 
ability of MTBs’ to reach a treatment decision is dependent on presentation of every type of 
information. This hypothesis was partially supported: information regarding patients’ psychosocial 
circumstances increased teams’ ability to reach a decision, whereas information on comorbidities 
reduced it. Our second hypothesis (H2) was that the ability of MTBs’ to reach decisions is 
dependent on contributions from each specialty represented at the MTB. We found that the input of 
surgeons, radiologists, pathologists, and oncologists increased teams’ ability to make a decision, 
while the input of nurses reduced it. The contribution of the meeting chairperson did not have a 
significant impact on decision-making.  
To the best of our knowledge this is the first study to demonstrate which aspects of MTB meetings 
are linked to their ability to reach clinical decisions. The finding that all disciplines in MTBs have 
an impact on decision-making is significant and supports the model of a multidisciplinary approach 
to cancer care. In addition, our findings suggest that information is necessary, but on its own not 
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sufficient for clinical decision-making. Expert review and discussion of this clinical information 
drives the decision-making process.  
A novel and interesting finding of this study is that some elements of the decision-making process 
influence the ability of the MTB to reach a decision more than others, and, more importantly, in 
different ways. Specifically, nursing inputs and patient comorbidities were found to decrease the 
probability of reaching a decision, in contrast to every other element. This finding is surprising for a 
number of reasons. Firstly, there is strong evidence that nurses play an important role within 
multidisciplinary teams to coordinate care, and communicate with patients. Secondly, nurses are 
better placed than physicians at obtaining and making sense of information about patients’ 
psychological and social circumstances as well as their beliefs about and preferences for treatment; 
information that is positively associated with reaching a decision. Thirdly, previous research has 
shown that information on patients’ comorbidities is important for ensuring that MTB decisions are 
clinically appropriate, as failure to integrate such information could result in decisions that are at 
best not implementable, and at worst dangerous [8, 25-27].  
One possible explanation for our findings may be that the input of nurses and the integration of 
information on comorbid conditions are actually indicators of case complexity – which makes 
decision making harder for a team. Cases where input from nurses about patients’ current needs / 
state of health, as well as information on comorbidities is important are likely not straightforward. 
For such cases the standard management options may not appropriate, and therefore decisions may 
require further effort by the team. For instance, further discussion with family and relatives may be 
necessary before a treatment plan is put in place. It may be then that MTBs should redouble their 
efforts to include such inputs into decision-making where cases are complex to ensure that 
management decisions are appropriate and desirable for patients. Anecdotally, it is generally 
apparent what constitutes a complex case, although further research is needed to define and quantify 
complexity and its effect on MTB decision-making. 
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A further possible explanation of these results may be offered by the statistical methods used. It is 
known that predictor variables can change in the presence of other variables in regression 
modelling. For instance, in the univariate regression (see Table 1) where each variable is entered in 
to the model on its own, it is apparent that nurses’ input and comorbidities have a positive 
association with MTB decisions. However, this changes when other variables are taken into account 
in the multiple regression (see Table 2): here nurses’ input and comorbidities change from being 
positive to being negative predictors. We found that psychosocial information and comorbidities are 
highly correlated, and in fact they correlated more with nursing rather than with physician inputs. It 
is thus reasonable to suggest that the presence of psychosocial variable in the multiple regression 
replaces what is explained by comorbidities in a univariate model – in other words, the 
psychosocial variable is partially carrying the effect of comorbidities.  
While our study shows that patient psychosocial information facilitates MTB decision-making, 
according to patient reports it can be inadequately addressed by health care providers and therefore, 
unsurprisingly, is then underrepresented in MTBs [7-11]. All patients, and cancer patients in 
particular, are faced not only with a physical burden, but also with the psychological and social 
consequence of illness. The psychosocial correlates of a diagnosis of cancer are many – including 
poor psychological adjustment to cancer, weakened coping abilities, emotional distress, impaired 
cognition, increased mental illness, limitations in daily activities, pain, fatigue, insufficient material 
resources and reduced employment - and are related to poor clinical outcomes [10]. This is reflected 
in guidance by the Institute of Medicine, which lays out a standard of quality cancer care mandating 
the integration of psychosocial factors into routine cancer care, from diagnosis to survivorship for 
every patient [10]. Further research is needed to evaluate quality of decisions against patients’ needs 
and values, and explore how such information can be effectively integrated into MTB decision-
making in order to further enhance the quality of care provided.  
One last finding of interest was the lack of impact of the MTB chair. MTB chairs have an indirect 
influence on team’s decision-making since their role is to facilitate discussion. When the MTB 
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meeting is functioning well and decisions are being reached, the chair may not be required to 
contribute directly and therefore does not score highly on observational evaluation. If the MTB 
decision-making is not optimal, the chair may be required to intervene more often – but the team 
may still be unable to make decisions. From a measurement point of view the two patterns may thus 
cancel each other out. It is arguable that the MTB-MODe does not capture the complex role of the 
chairperson in enough detail to allow accurate statistical modelling of such complex chairing skills. 
We are exploring these in prospective investigations aimed at clarifying the role and input of the 
chairperson, and constructing a more detailed evaluation tool for chairing skills [28]. 
Limitations and Generalizability 
The participants in our study were aware that they were being observed, hence we cannot rule out 
observer bias and the Hawthorne effect (namely, teams changing their usual behavior due to being 
observed). While this is a natural limitation to all observational evaluations, in our study, the 
evaluators were all surgeons, the presence of whom within a MTB is natural. Furthermore, although 
we have made an attempt to control for the tumor type/center, we acknowledge that the data was 
derived from different institutions and MTBs, and that team and organizational cultures could have 
influenced outcomes. This may have confounded institutional versus team- or tumor-specific effects 
on team decision-making. Future work should nonetheless explore a stratified sample of cases 
across hospitals and tumors, and help gain better understanding of how these differences affect team 
outcome. Lastly, although this is a large-scale study for its nature (in vivo observations), 
generalizability of our findings may be limited to the most common cancer MTBs within the 
English NHS. Replication and assessment of generalizability of the findings to other cancers 
(especially lower-frequency cancers) and health systems needs to be examined further to determine 
generalizability. 
Conclusions 
Previous research has shown inequality of contribution to case discussions in MTBs with nurses 
being underrepresented, and suboptimal information sharing with more emphasis on biomedical 
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information than patient psychosocial aspects and comorbidities. Our study demonstrates for the 
first time that the patient psychosocial information and inputs by all core disciplines in MTBs are 
important since they stimulate teams’ ability to make clinical decisions. Nursing inputs and 
information on patient comorbidities are associated with difficulty in reaching clinical decisions, 
suggesting that such cases are complex, and that for difficult cases treatment recommendations may 
not be possible at the point of the team meeting. Building on our findings, further research could 
investigate (i) what constitutes a complex case for discussion, and (ii) how to better integrate patient 
psychosocial information into MTB decision-making. 
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Figure Legends 
Figure 1. Metric for the observation of decision-making used to observe multidisciplinary tumor 
boards [7] 
Figure 2. The relationship between the significant predictor variables and probability of making a 
treatment decision in cancer multidisciplinary tumor boards (MTBs) 
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Table 1. Univariate logistic regression models predicting treatment recommendation from the 
items of the Metric for the Observation of Decision-making in Multidisciplinary Tumor Boards 
(MTB-MODe)  
Note. Significance level set to 0.15. B, regression coefficient; SE, standard error; OR, odds ratio; CI, Confidence 
Interval. N=1,045. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Unadjusted   Adjusted for tumor type 
   95% CI for OR    95% CI for OR  
 
MTB-MODe items 
B (SE) OR Lower - 
Upper 
P-value* 
 
B (SE) OR Lower - 
Upper 
P-value* 
IN
F
O
R
M
A
T
IO
N
  
Comorbidities 0.15 (0.07) 1.16 1.00-1.33 0.04  0.15 (0.07) 1.16 1.00-1.33 0.04 
Psychosocial information 0.35 (0.09) 1.43 1.20-1.69 0.001  0.35 (0.09) 1.43 1.20-1.69 0.001 
Patient history 0.56 (0.09) 1.76 1.47-2.10 0.001  0.56 (0.09) 1.76 1.47-2.10 0.001 
Patient views 0.27 (0.1) 1.31 1.09-1.59 0.01  0.29 (0.1) 1.33 1.09-1.59 0.01 
Radiological information 0.3 (0.05) 1.35 1.21-1.49 0.001  0.33 (0.06) 1.40 1.21-1.49 0.001 
Pathological information 0.37 (0.7) 1.44 1.26-1.69 0.001  0.38 (0.72) 1.47 1.26-1.69 0.001 
C
O
N
T
R
IB
U
T
IO
N
 
Surgeons’ input 0.34 (0.05) 1.40 1.29-1.55 0.001  0.59 (0.07) 1.81 1.36-1.68 0.001 
Radiologists’ input 0.42 (0.05) 1.51 1.36-1.68 0.001  0.39 (0.06) 1.47 1.29-1.55 0.001 
Pathologists’ input 0.28 (0.07) 1.32 1.15-1.52 0.001  0.29 (0.07) 1.33 1.15-1.52 0.001 
Oncologists’ input 0.28 (0.06) 1.33 1.17-1.50 0.001  0.29 (0.06) 1.33 1.17-1.50 0.001 
Nurses’ input 0.14 (0.06) 1.15 1.01-1.30 0.03  0.14 (0.06) 1.15 1.01-1.30 0.03 
Chairs’ input -0.06 (0.8) 0.95 0.80-1.11 0.50  -0.05 (0.8) 0.95 0.80-1.11 0.52 
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Table 2. Multiple logistic regression models predicting treatment recommendation from the items 
of the Metric for the Observation of Decision-making in Multidisciplinary Tumor Boards (MTB-
MODe)  
Note. *Significance level set to 0.10.  B, regression coefficient; SE, standard error; OR, odds ratio; CI, Confidence 
Interval. N = 1,045. -2.LL = 671.06; Nagelkerke R2 = 0.27.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Unadjusted   Adjusted for tumor type 
   95% CI for OR    95% CI for OR  
 
MTB-MODe items 
B (SE) OR Lower - 
Upper 
P-value* 
 
B (SE) OR Lower - 
Upper 
P-value* 
IN
F
O
R
M
A
T
IO
N
  
Comorbidities -0.18 (0.92) 0.84 0.70-1.00 0.05  -0.18 (0.09) 0.83 0.70-1.00 0.06 
Psychosocial information 0.32 (0.10) 1.38 1.12-1.68 0.01  0.30 (0.10) 1.35 1.10-1.65 0.01 
Patient history 0.11 (0.11) 1.12 0.90-1.39 0.31  0.11 (0.11) 1.12 0.90-1.39 0.31 
Patient views -0.03 (0.11) 0.97 0.79-1.20 0.81  0.02 (0.11) 1.02 0.82-1.27 0.87 
Radiological information 0.12 (0.09) 1.12 0.94-1.35 0.21  0.08 (0.10) 1.09 0.90-1.31 0.38 
Pathological information 0.15 (0.11) 1.16 0.94-1.44 0.16  0.13 (0.11) 1.14 0.93-1.41 0.21 
C
O
N
T
R
IB
U
T
IO
N
  
Surgeons’ input 0.51 (0.07) 1.66 1.46-1.89 0.001  0.48 (0.08) 1.62 1.39-1.88 0.001 
Radiologists’ input 0.47 (0.06) 1.60 1.42-1.81 0.001  0.39 (0.09) 1.48 1.23-1.78 0.001 
Pathologists’ input 0.28 (0.08) 1.33 1.15-1.54 0.001  0.21 (0.10) 1.23 1.01-1.50 0.04 
Oncologists’ input 0.15 (0.07) 1.16 1.01-1.34 0.04  0.12 (0.07) 1.13 0.98-1.31 0.10 
Nurses’ input -0.16 (0.08) 0.85 0.73-0.99 0.05  -0.14 (0.09) 0.87 0.73-1.03 0.10 
 Constant -1.95 (0.51) 0.14    -1.93 (0.35) 0.15   
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Table 3. Partial correlations (controlling for tumor type) between significant predictor variables  
 
 Comorbidities 
Nurses’ 
input 
Oncologists’ 
input 
Radiologists’ 
input 
Pathologists’ 
input 
Surgeons’ 
input 
Psychosocial 
information 
0.50 0.34 0.19 0.16 0.03 0.07 
Comorbidities 
 
0.30 0.14 0.16 0.06 0.00 
Note. N = 1,042. Table entries are Pearson r coefficients.   
 
 
 
